Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative rapid iron polymaltose infusion for peri-operative anaemia
ACTRN12612000423819Phase 4Not yet recruiting
- Sponsor
- Fremantle Hospital
- Start
- Jul 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of iron polymaltose in iron deficiency anemia (IDA), sponsored by Fremantle Hospital. Primary endpoint: Incidence of significant hypotension after iron polymaltose infusion. Planned start Jul 2012; status: not yet recruiting.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12612000423819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000423819.